medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2017, Number 4

<< Back Next >>

Rev Mex Urol 2017; 77 (4)

Radical nephrectomy plus level IV thrombus excision with cardiopulmonary bypass, deep hypothermia, and circulatory arrest: a case report and literature review

Izquierdo-Luna JS, Campos-Salcedo JG, Estrada-Carrasco CE, Torres-Gómez JJ, Hernández-Palacios GA, Díaz-Gómez C

Language: Spanish
References: 11
Page: 307-311
PDF size: 303.91 Kb.


ABSTRACT

Background: Renal cell carcinoma has a unique propensity for vascular invasion. Level IV tumor thrombi require multidisciplinary collaboration. The best strategy for managing such patients is still a subject of debate.
Clinical case: A 56-year-old man presented with typical symptoms of kidney cancer and during work-up a tumor thrombus in the right atrium and pulmonary metastases were detected. A multidisciplinary team performed radical nephrectomy plus resection of the thrombus through cardiopulmonary bypass, deep hypothermia, and circulatory arrest, with excellent patient progression. Treatment with tyrosinekinase inhibitors was then begun and at the 11th month of follow-up, the patient has good quality of life and his disease is stable.
Conclusion: Cytoreductive nephrectomy before systemic therapy is recommended in stage IV patients with a potentially resectable tumor. The role of targeted therapy in histologic results other than clear cell disease is not well defined. Enrollment in clinical trials is the preferred strategy for those types of tumor.


REFERENCES

  1. Hevia V, Ciancio G, Gómez V. Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: tips, tricks and oncological results. Springerplus. 2016;5:132.

  2. Posacioglu H, Ayik M, Zeytunlu M, el al. Management of renal cell carcinoma with intracardiac extension. J Card Surg. 2008;23:754-758.

  3. Gaudino M, Lau C, Cammertoni F, et al. Surgical treatment of renal cell carcinoma with cavoatrial involvement: a systematic review of literature. Ann Thorac Surg. 2016;101(3);1213:21.

  4. Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987;59(5):390-395.

  5. Lu HT, Chong JL, Othman N, et al. An uncommon and insidious presentation of renal cell carcinoma with tumor extending into the inferior vena cava and right atrium: J Med Case Rep. 2016;10(1):109.

  6. Klatte T, Pantuck AJ, Riggs SB, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol. 2007;178:1189-1195.

  7. Lardas M, Stewart F, Scrimgeour D, el al. Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena cava thrombus. Eur Urol. 2016;70:265-280.

  8. Abel EJ, Thompson RH, Margulis V, et al. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014;66:584-592.

  9. Tilki D, Nguyen H, Dall’Era MA, et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. Eur Urol. 66(3); 577-83. 2013.

  10. Motzer RJ, Jonasch E, Agarwal N, et al. Kidney cancer guideline version 1.2015). National Comprehensive Cancer Network, 2015;13(2);151-9.

  11. Motzer RJ, Hutson TE, Cella D, et al. Pazopanib versus Sunitinib in metastastic renal-cell carcinoma. N Engl J Med. 2013;369(8):722-731.




2020     |     www.medigraphic.com